Morning Bell With Jim Cramer: Pfizer Vaccine Approval Status

Dow futures slip lower as stocks mixed as focus shifts to U.S. labor markets, stimulus talks following vaccine breakthroughs.

In the last episode of Mad Money, Jim Cramer that demand is what will define the next leg of the bull market. Now that COVID-19 vaccines are around the corner, everything that was put on hold during the pandemic will soon be back in vogue.

TheStreet’s Katherine Ross and Cramer are talking about the UK’s approval of the Pfizer vaccine, buying Thermo Fisher, and the stimulus deal.

Pfizer Stock: Buy or Sell?

Pfizer Inc.  (PFE) – Get Report, as well as its German partner BioNTech, received the first formal approval for any globally-available coronavirus vaccine Wednesday following a nod from health officials in Britain.

The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) agreed to the emergency use of the pair’s messenger-RNA based vaccine less than a month after data from late-stage trials were published in November and an order of 40 million doses from the Boris Johnson-lead government.

Source Article

  • Partner links